Cartesian secures funding to 'accelerate' launch; Editas sells $125M in stock
💰 Cartesian Therapeutic’s $150M financing: The Maryland biotech secured $50 million in an initial tranche from K2 HealthVentures. The credit facility will help...
💰 Cartesian Therapeutic’s $150M financing: The Maryland biotech secured $50 million in an initial tranche from K2 HealthVentures. The credit facility will help the company “accelerate” its commercial launch work in ...